Cite

HARVARD Citation

    Lefort, M. et al. (2020). Long‐term effect of first‐line injectable multiple sclerosis treatments: Input of a time‐dependent propensity score. Pharmacoepidemiology and drug safety. 29 (12), pp. 1680-1688. [Online]. 
  
Back to record